The question put to the court: A bootstrapped $2M compliance SaaS, profitable and growing steadily, gets an unsolicited $3M term sheet at $12M pre with a 30-day clock. Take the swing or decline?
Nine people, real profits, three straight years of steady growth, and a founder who never went looking for money. Then a respected fund slides $3M across the table with a board seat attached and a month to answer. The court's job: figure out what the money is actually for, and whether the answer is worth a fifth of the company.
CASE FILE № 5 · CONVENED JULY 15, 2026
The question put to the court: A bootstrapped $2M compliance SaaS, profitable and growing steadily, gets an unsolicited $3M term sheet at $12M pre with a 30-day clock. Take the swing or decline?
Nine people, real profits, three straight years of steady growth, and a founder who never went looking for money. Then a respected fund slides $3M across the table with a board seat attached and a month to answer. The court's job: figure out what the money is actually for, and whether the answer is worth a fifth of the company.
Turn down the $3M and stay bootstrapped. Don't counter on price: the terms are market-fair, and that was never the problem. Before the 30-day window closes, run two cheap probes: personally try to verbally close one senior sales hire paid out of existing profit, and ask the fund a single question, observer seat with no growth covenant. And this week, before anything else, reconstruct the last twelve months of lost deals against the funded rival's pricing and hiring, because that one unknown outweighs every other number in this file.
| Option | Why it lost or won |
|---|---|
| A · killed on the hurdle | The verified math: without the round, steady compounding reaches $5.71M by year four with the founder keeping nearly everything. With it, growth has to clear roughly 45 percent a year for four straight years, through a tripled sales team run by someone who has never managed more than nine people, just to beat the path he is already on. The sheet is priced for a company that burns cash. He distributes it. Mismatch. |
| pointless · terms were fair | The multiple sits above the bootstrapped-SaaS benchmark and the dilution sits at the market median, both checked live. There is nothing to negotiate because price was never the objection: the objection is the plan the money demands. Countering would spend goodwill to fix the one part of the deal that was fine. |
| B · wins, eyes open | The winning path, held honestly: it wins on operating math that stands even if no term sheet ever appears again, because the raise-later fallback was deliberately stripped from the reasoning. Its one real exposure is the funded rival, which is why the verdict's first action is a loss-deal autopsy, not a celebration. |
The final review kept the call and stripped its comforts: the come-back-later promise was withdrawn as wishful, and the consolidation wave moved from someday to now.
Vindicated Your read that you are hungrier with constraints survived a direct attack: $2M of revenue, real margins, and zero outside capital is the receipt, and even the model paid to break this verdict conceded it is self-knowledge, not mythology.
Honored Your admission that you have no plan that actually needs $3M became the spine of the ruling. The court did not invent a plan to justify the money; it respected the absence of one.
Every line above carries a receipt in the run record. This court affirms claims, not egos; when it says you were right, it is because the claim survived the trial.
All reached decline by different roads, asset math, management risk, and hurdle arithmetic, which is the good kind of agreement. The attack landed real hits and the verdict paid for them on the record: two comfortable assumptions withdrawn, the confidence cut, and the one genuine unknown, the funded rival's real economics, promoted to the first action in the plan.
Strength is set by the weakest surviving assumption, not the average. Easy calls do not come to court, so verdicts here live mostly in the 40s to 60s, and movement means more than level. The raw number for this run stays on the record: stable 2/2 · 72%. The court's own final review cut this number before it ruled, movement in the uncomfortable direction, with the reasons on the docket in the web record.
The hurdle arithmetic: the round only beats the current path at sustained growth rates nothing in his record supports, through a team that does not exist. The purpose mismatch: market-fair terms built for a cash-burning trajectory, offered to a company that distributes its profits. The founder's self-read: hungrier with constraints survived a direct attack, with his own operating record as the receipt.
No seat dissented on the call; the surviving opposition is the attacker's warning that decline-and-compound may quietly be decline-and-slowly-lose against a funded rival; the loss-deal autopsy coming back hot, the rival converting his keywords into closed deals at sane economics, reopens everything immediately, which is why it is the plan's first action rather than a footnote.
The full trial, with every attack and its answer, is below in the record.
Several independent models argued this, each assigned a different way of thinking, their arguments stripped of names before a judge model ruled. All reached decline by different roads, asset math, management risk, and hurdle arithmetic, and the court named that convergence honestly instead of manufacturing a fight. The attack still changed the record: two comfortable assumptions were withdrawn, the raise-later fallback was stripped entirely, and the final deliberation ran twice from scratch, agreeing both times.
The accordions above are the curated story. This is the full docket: every hit both adversaries landed, what the court did about each, and how it was disposed. Nothing is cherry-picked; where a hit was conceded, the tag says conceded.
| # | The attack | The court's answer | Disposition |
|---|---|---|---|
| Wave 1 · every claim checked live An independent checker re-verified the record before any attack: seven claims confirmed including the load-bearing benchmarks, ten held as unverified, the founder's declared facts taken as his, zero fabrications. | |||
| W1·1 | The valuation and dilution benchmarks anchoring the terms-are-fair finding could have been folklore. | Confirmed live: the multiple benchmark and the median-dilution figure both checked out against their sources, which is what let the court say the price was never the problem. | Confirmed · held |
| W1·2 | The headline hurdle rate could be a number wearing a costume. | Labeled honestly: the compounding and break-even pieces were verifier-confirmed, and the 45-to-49 composite is marked as an estimate assembled from confirmed parts. An elite-multiple claim from one seat stayed unverified and carries no weight. | Labeled · quarantined |
| Wave 2 · the attack on the verdict An adversary model went after the decline's comforts and landed real hits: two assumptions withdrawn, the rival risk promoted to first homework, confidence cut on the record. | |||
| W2·1 | The comfortable assumption that this fund, or any fund, welcomes him back later is wishful thinking. | Conceded and withdrawn. Seed-to-A conversion sits in a band nobody could verify tightly, the market's attention is elsewhere, and walking away is not free. The ruling was rebuilt to not depend on ever raising again. | Conceded · withdrawn |
| W2·2 | Consolidation in his sector is not a someday event: the acquisition wave is running now. | Conceded on timing, held on implication: the wave being live makes the clean unencumbered company a better target, not a worse one, and a preference stack plus board seat complicates exactly that story. A judgment call, labeled as one. | Conceded · reframed |
| W2·3 | A failed 21-day hire search proves nothing about his ability to build a team; the probe is biased toward the answer the court already picked. | Conceded as nuance and written into the plan: a whiffed probe is weak evidence, not proof. But the burden of proof sits on the thesis asking for a fifth of the company, and an unproven thesis does not earn it by Day 30. | Conceded · burden named |
| W2·4 | The funded rival may already be converting his keywords into his customers, making the compounding baseline a fiction. | Landed as the verdict's one real unknown: unresolvable from the record, so promoted to the first action in the plan, a twelve-month loss-deal autopsy this week, with a pre-registered flip if it comes back hot. | Landed · homework first |
| Wave 3 · the counter-attack on the alternatives A second adversarial pass argued the brave case for taking the money and the diplomatic case for countering. The first broke on verified arithmetic; the second died on the finding that the price was never the problem. | |||
| W3·1 | The brave move is taking the money: capital compounds too, and the timid path just loses slower. | Broken on the verified hurdle: the funded path must sustain growth nothing in the record supports, through a team that does not exist, burning half a million or more before its first non-founder deal. Bravery that fails arithmetic is just spend. | Landed · round fell |
| W3·2 | At least counter: a better price or smaller check salvages something from a warm fund. | Rejected with the record's cleanest finding: the terms were already fair, so a counter negotiates the one part of the deal that was fine while signaling appetite for the part that was not. | Rejected · answered |
Three roads to the same no, then an attack that made the no more honest: fewer comforts, a real unknown promoted to homework, and a door left open for evidence instead of feelings.
| When | Gate |
|---|---|
| This week | Reconstruct the last twelve months of lost deals against the rival's pricing and hiring signals. If they are buying his customers profitably, that single fact outweighs every other number in this verdict and the survival clock is real. |
| By Day 21 | Two probes, both cheap: personally try to verbally close one senior sales hire, paid from existing profit with no round required, and ask the fund one question: observer seat, no growth covenant. Control-oriented funds almost never say yes, so read the answer as posture, not as a path. |
| By Day 28 | If the hire says yes AND the fund flexes on control, the funded path reopens and gets decided on evidence. If the hire search whiffs, that is weak evidence rather than proof, but the burden sits on the funded thesis, and an unproven thesis does not earn a fifth of the company by Day 30. |
| Day 30 · August 14, 2026 | Absent both signals, let the sheet expire, politely and without a counter. The evidence was absent. That is the reason, and it is a different reason than being allergic to money. |
year-four revenue at his existing pace, keeping nearly all of the company, with profits distributing the whole way: the benchmark the round has to beat
of roughly 45-percent-plus growth through a tripled sales team run by a founder who has never managed more than nine people: verified pieces, honest composite, brutal either way
first-year cost of the senior sales build before a single non-founder deal closes, in an industry where roughly half of such hires miss their number
The court refused to let the clock become the drama. The month gets spent converting unknowns into facts: the rival autopsy first, because it is the only finding that flips everything; then the one-hire probe, because it tests the funded thesis at a price of zero dilution; then the observer-seat question, because the answer reveals whether this fund wants a partner or a steering wheel. If the evidence shows up, the door reopens before the deadline. If it does not, the sheet expires for the right reason.
Pre-registered: by Day 28, either the verbal sales-hire close AND a control-flexible answer from the fund exist, reopening the funded path for a decision on evidence, or by Day 30 the sheet expires without a counter. Separately graded within the window: the loss-deal autopsy is complete, and if it shows the rival buying customers profitably, the decline is re-examined immediately rather than defended.
Every council verdict makes dated, checkable predictions. This one grades itself August 14: the probes ran, the autopsy is in hand, and the sheet was either re-opened on evidence or allowed to die politely. The scorecard fills in either way.